VP
ELEV

venBio Partners’s Elevation Oncology ELEV Stock Holding History

venBio Partners’s Portfolio ELEV Stock Details ELEV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-2,434,255
Closed -$6.57M – 7
2024
Q2 		$6.57M Sell
2,434,255
-261,878
-10% -$986K 2.84% 6
2024
Q1 		$13.8M Sell
2,696,133
-218,122
-7% -$707K 4.91% 5
2023
Q4 		$1.56M Hold
2,914,255
– – 0.23% 6
2023
Q3 		$1.93M Hold
2,914,255
– – 0.55% 7
2023
Q2 		$4.43M Buy
2,914,255
+1,047,916
+56% +$2.76M 1.6% 6
2023
Q1 		$3.55M Hold
1,866,339
– – 1.97% 6
2022
Q4 		$1.77M Hold
1,866,339
– – 0.55% 7
2022
Q3 		$2.11M Hold
1,866,339
– – 0.49% 8
2022
Q2 		$2.61M Sell
1,866,339
-741,828
-28% -$1.86M 0.74% 8
2022
Q1 		$6.57M Hold
2,608,167
– – 1.46% 9
2021
Q4 		$15.7M Hold
2,608,167
– – 2.83% 7
2021
Q3 		$20.3M Hold
2,608,167
– – 2.02% 6
2021
Q2 		$35.4M Buy
+2,608,167
New +$32.2M 4.18% 5

Other funds holding ELEV

FLSM
Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $761B AUM 31.28% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $15.3B AUM 50.95% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
ACM
Aisling Capital Management New York $476M AUM 128.63% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Hudson Bay Capital Management
Hudson Bay Capital Management Stamford, Connecticut $16.6B AUM 30.2% 1-Year Est. Return